Acceleration of new medicines–CMC lessons learned from emergency use authorizations

Abstract

Abstract The American Association of Pharmaceutical Scientists (AAPS) Chemistry, Manufacturing, and Control (CMC) Community hosted a virtual panel discussion on July 15, 2022, to provide a forum to discuss industry and regulator CMC challenges associated with emergency use authorizations.

Keywords

• Emergency use authorization
• Accelerated regulatory pathways
• Chemistry, Manufacturing, and Controls
• COVID-19